Xueli Mo
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Chinese expert consensus on endocrine therapy for breast cancer (2026 edition).
Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer
Published: November 19, 2025
Chinese expert consensus on clinical diagnosis and treatment of breast cancer targeting HER2.
Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer
Published: June 02, 2025
Anti-HER2 plus endocrine therapy versus anti-HER2 plus chemotherapy in hormone receptor-positive and HER2-positive metastatic breast cancer: a retrospective study.
Journal: International journal of clinical oncology
Published: May 05, 2025
A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancer.
Journal: Future oncology (London, England)
Published: December 04, 2024
Clinical application of totally implantable venous access ports for patients with breast cancer.
Journal: Asian journal of surgery
Published: May 13, 2020
Utility of totally implantable venous access ports in patients with breast cancer.
Journal: The breast journal
Published: May 10, 2019
Association of miR-1247-5p expression with clinicopathological parameters and prognosis in breast cancer.
Journal: International journal of experimental pathology
Published: January 19, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026